News
Latest valve and structural heart intelligence
Filter by Source
Filter by Tag
FDA approves pediatric pulmonary valve that grows with patients
The FDA approved the Autus Size-Adjustable Valve from Edwards Lifesciences, the first pulmonary valve replacement designed to expand with patient growth, reducing repeat surgeries in pediatric congenital heart disease. The pivotal study of 62 patients aged 18 months to 16 years demonstrated 100% freedom from device-related complications at 30 days, no reinterventions at 6 months, and favorable hemodynamics through 1 year with mean RVOT gradients ≤40 mmHg and less than moderate regurgitation.
Digest: This first-in-class balloon-expandable valve (13-22 mm) with polymeric leaflets addresses a critical unmet need in pediatric congenital valve disease by potentially eliminating multiple open-heart surgeries during childhood growth.
FDA approves first heart valve that grows with children
The FDA has approved the first pediatric heart valve prosthesis designed to grow with children as they develop. This represents a significant advancement in congenital valve replacement, potentially reducing the number of reoperations required in pediatric patients.
Digest: This approval addresses a critical unmet need in pediatric structural heart disease by eliminating the requirement for multiple valve replacements as children grow, which could substantially reduce surgical burden and improve long-term outcomes.
FDA Approves First Heart Valve Designed to Grow with Children
The FDA approved the Autus Size-Adjustable Valve, the first surgically implanted pulmonary valve designed to expand with pediatric growth, featuring novel polymeric leaflets rather than bioprosthetic tissue. The valve can be initially implanted at 13mm diameter for toddlers and balloon-expanded up to 22mm as the child matures, potentially reducing the need for multiple open-heart reoperations.
Digest: This landmark approval addresses a significant unmet need in congenital heart disease management and introduces a novel biomaterial approach that could influence future pediatric valve development across multiple positions.
Nicklaus Children's Hospital Performs Transcatheter Fontan Completion on Two-Year-Old Child
Nicklaus Children's Hospital performed one of the first transcatheter Fontan completions in the United States on a 2-year-old child with double-outlet right ventricle, using a catheter-based approach instead of traditional open-heart surgery. The patient recovered well and was discharged home, avoiding additional sternotomy for the final stage of single-ventricle palliation.
Digest: This represents an important expansion of minimally invasive techniques into complex congenital heart disease, potentially establishing a paradigm shift in Fontan completion that could reduce surgical morbidity and recovery time for single-ventricle patients.
Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down
A family filed a $17 million lawsuit alleging that a heart valve was implanted upside down in a young girl during cardiac surgery. The complaint suggests surgical error resulting in improper valve orientation and subsequent patient harm.
Digest: Surgical valve orientation errors, while rare, represent a critical quality and safety concern that can lead to valvular dysfunction, reoperation, and medico-legal implications for cardiac surgery programs.